@article{JTD6964,
author = {Ke Ma and Zhitao Gu and Yongtao Han and Jianhua Fu and Yi Shen and Yucheng Wei and Lijie Tan and Peng Zhang and Chun Chen and Renquan Zhang and Yin Li and Keneng Chen and Hezhong Chen and Yongyu Liu and Youbing Cui and Yun Wang and Liewen Pang and Zhentao Yu and Xinming Zhou and Yangchun Liu and Yuan Liu and Wentao Fang and Members of the Chinese Alliance for Research in Thymomas},
title = {The application of postoperative chemotherapy in thymic tumors and its prognostic effect},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {4},
year = {2016},
keywords = {},
abstract = {Background: To study the role of postoperative chemotherapy and its prognostic effect in Masaoka-Koga stage III and IV thymic tumors.
Methods: Between 1994 and 2012, 1,700 patients with thymic tumors who underwent surgery without neoajuvant therapy were enrolled for the study. Among them, 665 patients in Masaoka-Koga stage III and IV were further analyzed to evaluate the clinical value of postoperative chemotherapy. The Kaplan-Meier method was used to obtain the survival curve of the patients divided into different subgroups, and the Cox regression analysis was used to make multivariate analysis on the factors affecting prognosis. A Propensity-Matched Study was used to evaluate the clinical value of chemotherapy.
Results: Two-hundred and twenty-one patients were treated with postoperative chemotherapy, while the rest 444 cases were not. The two groups showed significant differences (P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/6964}
}